Equity Overview
Price & Market Data
Price: $4.99
Daily Change: $0.00 / 0.00%
Range: $4.98 - $4.99
Market Cap: $260,645,232
Volume: 260,894
Company Details
Employees: 65
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. 2seventy bio, Inc. was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.